PT Diastika Biotekindo Tbk (ISX:CHEK) Institutional Ownership: 0.00% (As of Sep. 15, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ISX:CHEK PT Diastika Biotekindo Tbk ISX:CHEK
2 GF Score
Price Rp128.00
! 1 Warning Sign
View Full Analysis

What is PT Diastika Biotekindo Tbk Institutional Ownership?

PT Diastika Biotekindo Tbk ISX:CHEK 2 Institutional Ownership is 0.00% as of Sep. 15, 2026. GuruFocus rates ISX:CHEK with a GF Score™ of 2/100. The stock has 1 warning sign investors should review.

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, PT Diastika Biotekindo Tbk's institutional ownership is 0.00%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, PT Diastika Biotekindo Tbk's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, PT Diastika Biotekindo Tbk's Float Percentage Of Total Shares Outstanding is 0.00%.

PT Diastika Biotekindo Tbk Institutional Ownership Historical Data

* Premium members only.

The historical data trend for PT Diastika Biotekindo Tbk's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PT Diastika Biotekindo Tbk Institutional Ownership Chart

PT Diastika Biotekindo Tbk Annual Data
Trend
Institutional Ownership

PT Diastika Biotekindo Tbk Quarterly Data
Institutional Ownership
ISX:CHEK
2GF Score
PT Diastika Biotekindo Tbk ISX:CHEK
Institutional Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

PT Diastika Biotekindo Tbk Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

What does a Institutional Ownership of 0.00% mean?
PT Diastika Biotekindo Tbk (ISX:CHEK) has a Institutional Ownership of 0.00% as of Sep. 15, 2026. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on PT Diastika Biotekindo Tbk and its competitors.
Is PT Diastika Biotekindo Tbk's Institutional Ownership too high?
PT Diastika Biotekindo Tbk's current Institutional Ownership is 0.00%. Overall, PT Diastika Biotekindo Tbk has a GF Score™ of 2/100, reflecting its overall financial health beyond just this single metric.
How does PT Diastika Biotekindo Tbk's Institutional Ownership compare to MCK and COR?
PT Diastika Biotekindo Tbk's Institutional Ownership of 0.00% can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Institutional Ownership for a Medical Distribution company?
A good Institutional Ownership depends on the Medical Distribution industry context. However, Institutional Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Institutional Ownership mean?
A high Institutional Ownership can signal that a stock is expensive relative to its fundamentals. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on PT Diastika Biotekindo Tbk and its competitors. PT Diastika Biotekindo Tbk's current Institutional Ownership is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Diastika Biotekindo Tbk stock overvalued right now?
PT Diastika Biotekindo Tbk (ISX:CHEK) has a current Institutional Ownership of 0.00%. The current Institutional Ownership is 0.00%. PT Diastika Biotekindo Tbk's overall GF Score™ is 2/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Institutional Ownership calculated?
Institutional Ownership is calculated from a company's financial statements. For PT Diastika Biotekindo Tbk (ISX:CHEK), the current Institutional Ownership is 0.00% as of Sep. 15, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

PT Diastika Biotekindo Tbk Business Description

Address Jalan Rawagelam V, Kawasan Industri Pulogadung, Block L, No. Kav 11-13, Gedung Etana Lantai 3, Desa/Kelurahan Jatinegara, Kec. Cakung, Kota Adm. Jakarta Timur, Jakarta, IDN, 13930
PT Diastika Biotekindo Tbk is engaged in providing medical and laboratory equipment solutions in Indonesia. It is engaged in the wholesale trading of laboratory equipment, pharmaceutical products, and medical devices for human use. The company is also involved in wholesale trading of radioactive substances and ionizing radiation generators, and undertakes activities related to the testing and/or calibration of medical devices, as well as the inspection of healthcare facilities and infrastructure. Its product offerings mainly include devices like hematology analyzer, pipette, hemoglobin testing system, etc. The company's operating segments are: Diagnostics Group, which generates the maximum revenue, and Life Sciences Group. Geographically, all of its revenue is derived from Indonesia.
2GF Score

Get the complete analysis for ISX:CHEK

Institutional Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

Rp128.00
Price